Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07712146

Femoral Nerve Gliding Versus Lumbopelvic Manipulation in Management of Patellofemoral Pain Syndrome

The present study is the first one to compare the effectiveness of adding (FNG) versus (LPM ) to conventional exercise therapy in pain, knee functional abilities, hip extension ROM and femoral nerve electrophysiological studies among those with PFPS.

This study will be conducted at the outpatient clinic of faculty of Physical Therapy, Cairo University Sixty patients with unilateral PFPS referred from an orthopaedic surgeon for selection criteria, will be included in the study. Measurement procedures, treatment procedures, and the study's goal will be explained to each patient before participation in the study. After being informed about the study aim, they will be asked to sign an informed consent for their approval to participate

The study patients will be randomly assigned into three groups

* Group A: control group will receive conventional hip-knee focused exercises only. * Group B: study group will receive FNG in addition to the same conventional hip-knee focused exercises. * Group C: study group will receive LPM in addition to the same hip-knee focused exercises All patients will receive 2 sessions/week for 6 weeks (12 sessions). They will be instructed to do the conventional hip-knee exercises at least two times per day. Each session will last for 20-30 minutes.

Patients diagnosed with unilateral PFPS will be screened based on the following inclusion and exclusion criteria A sample size of 60 participants will be appropriate. The computations will done using G* Power version 3.1.9.2 (Franz Faul, Uni Kiel, Germany) Randomization and blinding will be accomplished through using selected types such as A 1:1:1 allocation ratio will be employed for randomization using the website http://www.randomization.com. Blinding will be done on the patients, assessor, and statistician. All patients will be blinded to the task assigned to their group by ensuring they will be unaware of the exercises that the other group will complete. To maintain blinding, the intervention sessions will be administered to each member of the treatment group separately. Before the trial began, an impartial research assistant who will not participating in the study and he will keep the allocation sequence a secret. It will be kept hidden in opaque, sealed envelopes that will not be opened until baseline data will be collected

Outcome Measures:

1. Knee Pain 2. Knee function 3. Electro-physiological studies including (sensory nerve conduction velocity and distal latency). 4. Sagittal plane hip extension range of motion as a reference for femoral nerve mechanosensitivity changes - The outcomes will be measured at baseline (pre-test) and after 12sessions (after 6 weeks) (post-test) Then patients will receive 4 types of assessments step's including pain assessment using NRS then knee function assessment using arabic version of AKPS then hip extension ROM assessment using digital goniometer after that the electrophysiological studies including femoral nerve will be conducted using the computerized electromyography device for measuring selective parameters such nerve conduction velocity and its amplitude along with onset and peak latency.

Then Intervention will be completed as follow : All patients will receive two treatment session per week for six weeks (6 sessions), supervised by primary investigator. Separate sessions will be given to each treatment group's members. Each session lasted for 15-30 minutes. The three groups will receive hip-knee focused exercises approved by the clinical practice guidelines linked to the international classification of functioning, disability, and health from the Academy of Orthopedic Physical Therapy of the American Physical Therapy Association which consisted of hamstring/calf and ilio-tibial band stretching and hip/knee strengthening exercises. group B will receive FNG addition to hip-knee focused exercises. group C will receive LPM in addition to hip-knee focused exercise. The session of the control group will start with stretching exercises followed by strengthening exercises. On the other hand, the study group session will start with stretching exercises followed by femoral nerve glide and/or LPM then strengthening ex.

The study has a 3 null hypothesis

1. There will be no statistically significant effects of adding FNG to conventional exercises in patients with PFPS on:

A) Knee pain. B) Functional abilities. C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency). 2. There will be no statistically significant effects of adding LPM to conventional exercises in patients with PFPS on:

A) Knee pain. B) Functional abilities. C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency). 3. There will be no statistically significant difference between adding FNG versus LPM to conventional exercises in patients with PFPS on:

A) Knee pain. B) Functional abilities.C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of physical therapy-Cairo University

Cairo, Egypt

Location contact

Marihan Zakaria Aziz, PhD physical therapy

CONTACT

[email protected]

+201201227971

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of the subjects is between 18-35 years.
  • BMI will be from 18.5 to ≤ 29.5 Kg/m2
  • Anterior or retro patellar knee pain either on the dominant or non- dominant leg for at least 6 weeks duration .
  • Worst pain level in the previous month of up to 3cm on a 10cm numerical rating scale (NRS)
  • Per or retropatellar pain during at least 2 of the following activities: squatting, prolonged sitting, kneeling, running, jumping and climbing stairs
  • Showing 2 or more positive signs on the following clinical tests: Clarke's sign, Waldron test, active patellar grind test, patellar compression test, and palpation of the medial/lateral articular border of the patella .
  • Patients had positive femoral slump test with limited active lumber ROM.

Exclusion criteria

  • History of previous knee surgery and any knee pathology (meniscus tear, patellar tendinopathy, ligament sprain and osteoarthritis) .
  • Any systemic diseases and/or connective tissue disorders .
  • Bursitis and ligament tears .
  • Lower back dysfunction such as disc lesion, sciatica or spondylolisthesis.
  • participants that had undergone physiotherapy during the preceding 3 month.
  • Pregnant women.
  • Osteoporosis or recent fracture of the hip or spinal joints.• . Radiographic evidence or medical diagnosis of spinal instability (Grade II spondylolithesis or greater), spondyloarthritides, or severe spinal misalignment
  • Nervous system disease or disorder
  • .Lumbosacral nerve root compression (any of the following signs present) a. Positive straight leg raise (SLR) test less than 45°, marked paresis (<3/5 on manual muscle testing) involving a major muscle group of the lower extremity, diminished, and asymmetric (lower than uninvolved side), lower extremity muscle stretch reflex and diminished or absent sensation to pinprick in any lower extremity dermatome (D'Agati M 2022).

Treatment and study plan

Femoral nerve gliding technique

Other

The patients only of group B will be positioned on their asymptomatic side with their body in full flexion. The researcher then extended the patient's hip while keeping the knee flexed, holding the position for 2 seconds. when the patient reports soreness or pain. This mobilization technique will be repeated for 3 sets of 10 repetitions per session, with a total of 12 sessions over 6 wks

Other names: Neural mobilization

Lumbopelvic manipulation

Other

Patients if group C will receive lumbopelvic manipulation, which consists of applying rotational glide forces to the ipsilateral lumbopelvic region of the involved knee. Patients will lay supine and the therapist stood contralateral to the side which was to be manipulated. They will passively move onto their side, toward the side to be manipulated, and then interlocked their fingers behind their head. The researcher will passively rotate the patient, and then delivered a quick thrust to the anterior superior iliac spine in a posterior and inferior direction. Each patient received a maximum of two manipulations on the same side as the symptomatic knee

Exercises

Other

For control group (A) will start with the stretching exercises then starting with the hip extensors, then the hip abductors, and finally the hip external rotators. Next, knee strengthening exercises will be carried out, beginning with mini wall squats using a theraband around the distal thigh, followed by terminal knee extension exercise from a standing position, and finishing with seated knee extension exercise from 90° to 45° knee flexion.

Primary outcomes

  1. knee pain intensity

    Time frame: 6 weeks

    Pain intensity will be measured by the Arabic version of the Numeric Rating Scale during the last 24 hours. The minimum is zero and the maximum highest pain score is 10. The assessment will be done at baseline and after the last treatment session after 6 weeks

  2. functional disability

    Time frame: 6 weeks

    functional disability will be measured by the Arabic version of Kujala anterior knee pain questionnaire; higher scores means higher disability

Secondary outcomes

  1. femoral nerve conduction velocity by surface electromyography (sEMG).

    Time frame: 6 weeks

    Femoral nerve conduction velocity and its distal latency will be measured by surface electromyography (sEMG).

  2. Hip extension Rang of motion

    Time frame: 6 weeks

    Hip extension ROM will be assessed before and after the treatment in all groups using digital goniometer

Study contacts

Contact information is provided by the study sponsor or research team.

Ramez Fady Fahim, Master degree of orthopedic PT

CONTACT

[email protected]

0201211553069 ext. 0201288141231

Sponsors and collaborators

Lead sponsor

Marihan Aziz Zakaria

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 17, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.